Dbv Technologies operates in the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Dbv Technologies with three other
pharmaceutical manufacturers in Europe:
sales of 113.74 million Swedish Kronor [US$13.03 million]
(17.70 million Bulgarian Lev [US$10.10 million]
Biotec Pharmacon ASA
based in Norway
(71.90 million Norwegian Kroner [US$8.56 million]
Dbv Technologies reported sales of 9.08 million Euro (US$10.14 million)
December of 2016.
increase of 47.3%
versus 2015, when the company's sales were 6.17 million Euro.
Sales at Dbv Technologies have increased during each of the previous five years
(and since 2011, sales have increased a total of 7,107%).